Catalog4 refs
HMG (Human Menopausal Gonadotropin)
ReproductiveFertility & HormonalResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
granulosa cellsleydig cells
Overview
Human Menopausal Gonadotropin (HMG) is a hormonally active medication containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in a 1:1 ratio, extracted from the urine of postmenopausal women. FDA-approved for fertility treatment, HMG stimulates ovarian follicle development in women and spermatogenesis in men. While largely replaced by recombinant gonadotropins in some settings, HMG remains an effective and cost-efficient option for ovulation induction and assisted reproduction.
Primary Uses
Gonadal stimulation
Fertility and ovulation research
Steroidogenesis investigation
Spermatogenesis studies
Ovulation induction in anovulatory women
IVF stimulation protocols
PCOS ovulation induction
Male spermatogenesis promotion
Hypogonadotropic hypogonadism treatment in men
Testosterone support via LH replacement
Protocol Reference
Dose
75-150 IU for ovulation induction; 150-300 IU for IVF stimulation; 75-150 IU for male fertility (2-3x weekly)
Frequency
Daily during stimulation phase (7-12 days); 2-3x weekly for male fertility
Half-life
~32 hours (FSH component: 39-54 hours)
Route
Intramuscular · Subcutaneous
Evidence
Extensively Studied
Research References· 16
HMG Box↗
DOISpringerReference
Research Models
Human
Also in Reproductive